Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This report describes a 57-year-old woman with fibrosing alopecia in a pattern distribution, who experienced hair regrowth with combined treatment including hydroxychloroquine and other topical and oral therapies.

This study found that female pattern hair loss and acute telogen effluvium have distinct trichoscopic and histochemical characteristics, which may aid in their diagnosis and differentiation.

Panoramic Trichoscopy is a new, better way to assess widespread hair loss.

This report describes a case of Cronkhite-Canada syndrome diagnosed in a 54-year-old man with symptoms including gastrointestinal polyps, alopecia, skin hyperpigmentation, and severe diarrhea, who experienced significant symptom improvement with azathioprine.

This review discusses the concept and treatment of diffuse hair loss, known as Intithār al-Sha‘r, in the Unani system, drawing from classical Unani literature without reporting new clinical results.

This study found that thyroid dysfunctions were present in a significant number of women with diffuse hair loss, suggesting the importance of investigating thyroid functions in these patients.

This study found that dermoscopy can help differentiate between types of diffuse alopecia in females, with yellow dots common in telogen effluvium and hair diameter diversity over 20% significant in female androgenetic alopecia.

In this study, researchers explored the causes and treatment strategies for diffuse telogen effluvium, focusing on 60 patients with the condition linked to iron deficiency anemia, comparing the effectiveness of ferrous salts alone versus combined with Quilib lotion.

This review discusses the causes, diagnosis, and treatment approaches for telogen effluvium but presents no new clinical findings; novel treatments like ALRV5XR are highlighted as promising.

This study observed that low serum ferritin and vitamin D levels may contribute to diffuse hair loss in women.

This study found that treating diffuse alopecia associated with prior COVID-19 infection using a combination of Selencin (homeopathic drug) and Selencin Peptide Active (peptide lotion) significantly reduced hair loss and improved hair structure and volume in 34 patients over two months.

This case study highlights how trichoscopy helped differentiate between diffuse alopecia areata and trichotillomania in an 11-year-old girl, demonstrating its importance in distinguishing hair disorders with similar presentations.

This chapter reviews diffuse hair loss conditions like androgenetic alopecia, lichen planopilaris, telogen effluvium, and alopecia areata, but it provides no new clinical findings.

This study concluded that diffuse hair loss in women has a moderate to severe impact on their quality of life, especially among younger women and those with prolonged duration of hair loss.

This article highlights the prevalence of iron deficiency, with or without anemia, as a significant factor in diffuse nonscarring hair loss in women, particularly affecting certain groups such as menstruating women and vegetarians.

This review discusses telogen effluvium in women and suggests that combining minoxidil with supplementary therapies may enhance treatment outcomes, but it reports no new clinical results.

This review describes the role of iron deficiency in hair loss and explores the management of diffuse alopecia, emphasizing the potential of a new iron-based dietary supplement but reports no new clinical results.

In this study, women with diffuse hair loss reported that Proteoglycan Replacement Therapy with Nourkrin® improved hair growth and appearance, boosting their confidence and satisfaction with the treatment.

This study found that women with diffuse alopecia exhibited deficiencies in several trace elements, including sulfur, iron, and potassium, while men showed deficiencies in calcium, sulfur, and zinc.

A woman with severe hair loss regrew mostly white hair after treatment.

In this study, chronic telogen effluvium and female pattern hair loss were the most common types of non-scarring diffuse hair loss among Indian women aged 15-45, with anemia frequently present across cases.

This study investigated the role of serum iron, ferritin, zinc, and folic acid levels in women with diffuse hair loss but reports no findings.

This study found that female pattern hair loss is the most common type of diffuse hair loss in women, with significant associations observed between chronic telogen effluvium, low iron levels, and high total iron-binding capacity.

This review discusses the diagnosis and treatment of diffuse alopecia but reports no new results; the authors emphasize the importance of detailed history and examination for accurate diagnosis.

This article discusses a severe case of telogen effluvium following brow ptosis repair and stresses the importance of recognizing and addressing stress-induced hair loss, without presenting new clinical findings.

This study observed that serum Vitamin D3 levels were low among South Indian students with diffuse hair fall, highlighting global hypovitaminosis D as a concern and suggesting possible dietary or sunlight exposure influences.

This letter discusses the potential role of zinc deficiency in hypothyroid infants with alopecia due to levothyroxine overdose and reports no new results.

This case study identified the condition as Monilethrix in a 17-year-old female, characterized by a beaded hair appearance and linked to a genetic cause.

A woman's skin symptoms led to a diagnosis of systemic AL amyloidosis, but she died from sepsis shortly after.

This study found that young adults, particularly females, experiencing diffuse hair fall had significantly lower Vitamin D3 levels compared to their age-matched healthy counterparts.